Johnson & Johnson - 47 Year Dividend History | JNJ

Historical dividend payout and yield for Johnson & Johnson (JNJ) since 1972. The current TTM dividend payout for Johnson & Johnson (JNJ) as of June 18, 2019 is $3.80. The current dividend yield for Johnson & Johnson as of June 18, 2019 is 2.73%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $370.221B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $238.410B 13.92
Merck (MRK) United States $214.468B 18.47
Novartis AG (NVS) Switzerland $207.346B 17.92
Novo Nordisk (NVO) Denmark $124.644B 20.74
AbbVie (ABBV) United States $116.271B 9.61
Eli Lilly (LLY) United States $110.092B 20.43
Sanofi (SNY) France $106.468B 13.12
AstraZeneca (AZN) United Kingdom $101.265B 11.66
GlaxoSmithKline (GSK) United Kingdom $99.050B 12.56
Bristol-Myers Squibb (BMY) United States $78.857B 11.65